Autophagy is critical to the process of development because mouse models have shown that lack of autophagy leads to developmental arrest during the pre-implantation stage of embryogenesis. The process of autophagy is regulated through signaling pathways, which respond to the cellular environment. Therefore, any alteration in the environment may lead to the dysregulation of the autophagic process potentially resulting in cell death. Using both in vitro and in vivo models to study autophagy in the pre-implantation murine embryo, we observed that the cells respond to environmental stressors (i.e. hyperglycemic environment) by increasing activation of autophagy in a differential pattern within the embryo. This upregulation is accompanied by an increase in apoptosis, which appears to plateau at high concentrations of glucose. The activation of the autophagic pathway was further confirmed by an increase in GAPDH activity in both in vivo and in vitro hyperglycemic models, which has been linked to autophagy through the activation of the Atg12 gene. Furthermore, this increase in autophagy in response to a hyperglycemic environment was observed as early as the oocyte stage.
Introduction
Autophagy is a programmed method of protein degradation and recycling of the necessary cellular building blocks of glucose, amino acids, and fatty acids. This process has been shown to be critical to cell survival during the periods of nutrient and specifically glucose deprivation, as well as during the development and differentiation (Aki et al. 2003 , Mizushima et al. 2004 , Scott et al. 2004 , Singh et al. 2009 ). During the developmental progression from oocyte to cleavage stage embryo, maternal proteins and RNAs are degraded and quickly replaced by newly synthesized embryonic counterparts. Mizushima et al. have recently elucidated a physiological role of autophagy to aid in this process (Tsukamoto et al. 2008a (Tsukamoto et al. , 2008b . By creating an oocytespecific Atg5 (autophagy-related 5, a critical component in the formation of autophagosomes) knockout mouse, the authors determined that fertilization of Atg5 null oocytes with Atg5 null sperm resulted in developmental arrest between the four-and eight-cell stage. Fertilization of the Atg5 null oocyte with wild-type sperm; however, resulted in normal embryo development. They also demonstrated that protein-recycling rates were abnormal in the embryos entirely devoid of ATG5 and concluded that proper autophagic degradation within early embryos is essential for pre-implantation development. Results suggesting a role for autophagy during embryoid cavitation were also recently published (Qu et al. 2007 ). This group reported that loss of either Ambra1 (Beclin-1, required for the initiation of autophagosome formation) or Atg5, both essential autophagic genes, leads to failure of cavitation due to the persistence of cellular corpses in murine ESCs. These cells fail to display signals to indicate removal. This dysregulation is also associated with low levels of ATP. Overall, the lethality associated with the removal of this pathway indicates the critical roles that this pathway plays in embryo development, many of which may not be elucidated yet.
The activation of autophagy has been characterized as a survival mechanism in the prevention of cell death (Boya et al. 2005) . This role for autophagy has been reviewed elsewhere (Maiuri et al. 2007 , Thorburn 2008 . Briefly, the interplay between survival and autophagy is demonstrated by studies showing that lack of AMBRA1 expression leads to excessive apoptotic cell death with embryo lethality at a peri-implantation stage (Yue et al. 2003) . Although the role for autophagy as a pro-survival mechanism is well accepted, the idea that excess autophagy with elevated levels of autophagosomes leads to cell death is still in debate. However, it is accepted that excessive autophagy leads to cell death during ischemia (Akazawa et al. 2004) . Therefore, there may be certain circumstances in which this interrelationship exists. And while the mechanisms may not be entirely clear, recent studies suggest that oxidative stress plays a role in this switch from survival to death (Sakaida et al. 1990 , Grune et al. 2003 , Rodriguez-Enriquez et al. 2004 , Kiffin et al. 2006 .
In diabetes models, it has been postulated that autophagy is activated in certain tissues as a mechanism of protection against cellular damage resulting from oxidative stress. This activation is evident in the pancreatic b cells of diabetic animal models and humans (Fujitani et al. 2009 , Masini et al. 2009 ). Other tissues that exhibit an increased level of autophagy in diabetic models include the muscle, neuronal tissue, and liver (Amherdt et al. 1974 , Towns et al. 2005 . However, a decrease in autophagy-mediated protein turnover is observed in the renal cortex of the diabetic kidney (Sooparb et al. 2004) . Therefore, it appears that tissues may regulate autophagy differently in response to a diabetic environment, and thus, investigation of this pathway is important as a potential therapeutic target for problems associated with diabetes.
The uterine milieu plays an important role in the development and implantation of an embryo. Previously, we have determined that a maternal diabetic state in mice results in an increase in number of fetal resorptions and an increase in congenital malformations of the fetus. These deleterious effects resulted with only a 96-h exposure to the diabetic environment, as blastocyst stage embryos transferred from diabetic mothers into non-diabetic control mothers also displayed these phenotypes (Wyman et al. 2008) . In addition, we have shown that the hyperglycemic environment of the uterus, by treatment with high glucose, leads to an increase in apoptosis in the embryo (Moley et al. 1998a) . Therefore, we wanted to investigate the autophagic pathway in a diabetic milieu.
In this study, we present evidence that the preimplantation embryo alters autophagy in response to the external environment. The embryos respond to stressors including a known activator of autophagy and a hyperglycemic environment by increasing the activation of autophagy, identifying autophagy as a pathway for survival in the blastocyst. Furthermore, the embryonic response is differentially activated in what appears to be specific cell niches within the embryos.
Results

Embryonic autophagy is influenced by environment
Our laboratory and others have observed a basal level of autophagic activation during all stages of preimplantation embryonic development in mice (Cooper et al. 2008 , Tsukamoto et al. 2008a , 2008b . However, an autophagic response due to environmental stress or a known inhibitor has yet to be studied during this crucial developmental time period. It has been well established that MTOR is an upstream repressor of autophagy. Therefore, the MTOR inhibitor rapamycin is widely used to activate autophagy within in vitro systems. In order to investigate the embryonic response in the presence of an autophagic activator, we exposed morula stage embryos (76 h post-human chorionic gonadotropin (hCG)) to culture media containing either 1 or 5 mM rapamycin for 30 h and observed the levels of AMBRA1 and LC3 expression by immunofluorescence compared with the embryos treated with DMSO (vehicle control) ( Fig. 1A and C) . We observed autophagic activation as an increase in the levels of AMBRA1 protein expression in the treated groups. This activation was confirmed by LC3 protein expression, a major component of the autophagosomal membrane ( Fig. 1D and E (Fig. 1C ).
In addition, we examined the expression of LC3, a wellknown marker for autophagy, as it is localized to the autophagosomal membrane throughout the bulk of the autophagic process. The expression of LC3 was also detected in a sporadic pattern throughout the embryo; however, this pattern was different than that of AMBRA1 (Fig. 1E ). This pattern may represent a differential autophagic response in certain cell niches.
In addition, a cell death assay was used to determine whether the treatment affected cell quality. We found no significant difference in cell death, the percentage of apoptotic cells, between the rapamycin treated and the control groups; however, there was a difference in total cell number (Supplementary Figure 1A and B, see section on supplementary data given at the end of this article). This difference may be due to either a decrease in proliferation or a non-apoptotic cell death.
The amount of glucose in the environment is critical to baseline autophagy levels Due to the importance of autophagy in energy homeostasis in other tissues and the alterations of this pathway in diabetic models, we investigated autophagy in the developing embryo exposed to different glucose levels in vitro.
As an embryo transitions from the morula to blastocyst stage, the amount of environmental glucose is critical as the embryo switches using pyruvate and lactate as energy to glucose (Brown & Whittingham 1991 , Leese 1991 . In previous papers, we have determined that the hyperglycemic conditions present in the milieu of diabetic mothers leads to a decrease in glucose transporter expression, deceased intracellular glucose, and an increase in apoptosis in murine blastocysts (Moley et al. 1998a (Moley et al. , 1998b . In addition, when embryos were exposed to a hyperglycemic environment for 72 h and then transplanted to a control pseudo-pregnant foster mouse, an increased number of resorptions and malformations in the fetuses were observed (Wyman et al. 2008) . Therefore, the maternal environment and, in particular, the amount of glucose present are critical to fetal outcome.
To investigate whether the amount of glucose present in the environment alters the basal level of autophagy present in the embryos, we exposed the developing embryos to varying concentrations of glucose in vitro during morula to blastocyst transition for 30 h. We have previously determined that a level of 52 mM D-glucose closely mimics the phenotypic effects we observe in the embryos exposed to an in vivo diabetic environment, with similar apoptosis, glucose transporter downregulation, and decreased intracellular glucose (Moley et al. 1998a) . Following this exposure to high glucose, we then attempted to detect LC3 by immunofluorescence, as a marker for autophagosomes. At more physiological levels (5 mM glucose), a minimal level autophagy is observed. However, the levels of LC3 appear to increase as the embryos are cultured in higher concentrations of glucose ( Fig. 2A-E) . We anticipate that the drop in intracellular glucose triggers an autophagic response in a rescue attempt to recycle cellular substrates and generate alternative energy substrates.
To investigate the interchange between autophagy and apoptosis in the developing blastocyst, we repeated the experiment and used a cell death detection assay to determine the level of cell death occurring in each of the conditions. Previously, we have published results indicating an increase in apoptosis in embryos exposed to a hyperglycemic environment in vivo or in vitro (Moley et al. 1998a ). While we observed a similar result, the levels of apoptosis appear to plateau above 20 mM glucose concentrations (Fig. 2F-J) .
Therefore, we concluded that higher levels of cell stress induced by a diabetic milieu result in a dosedependent increase of autophagy, as measured by the autophagosomal marker LC3. Interestingly, the embryos appear to display an internal rheostat that controls the level of apoptosis that occurs. We speculate that this persistence of the cells within the blastocyst that do not undergo apoptosis but display a compensatory increase in autophagy may result in significant changes in these specific cells, thereby permanently altering the lineages derived from this cell of the blastocyst. These cellspecific lineage changes could be responsible for the occurrence of malformations and/or miscarriages of these fetuses.
Changes in GAPDH activity reflect autophagic activation and inhibition
Although it is well established that increased GAPDH activity triggers flux through the glycolytic pathway in general and triose metabolism specifically, a recent study has demonstrated a previously unknown role for GAPDH in signaling the activation of autophagy (Colell et al. 2007) . By overexpressing GAPDH, the investigators were able to protect the cells from caspaseindependent cell death and even promote cell survival. In addition, they showed that increased GAPDH activity leads to an elevation in intracellular ATP as well as upregulation of ATG12, an autophagic protein involved in the formation of the autophagosome. We chose GAPDH activity as a metabolic marker of the autophagic response in these embryos.
To test whether GAPDH activity could be used as a marker of autophagy in blastocysts, we measured the activity using microanalytic enzymatic assays (Passonneau & Lowry 1993) 
in individual blastocysts
Hyperglycemia increases blastocyst autophagy exposed to either DMSO as vehicle control or 5 mM rapamycin for 30 h to activate autophagy (Supplementary Figure 2A , see section on supplementary data given at the end of this article). The activity increased significantly over vehicle. Conversely, blastocysts were exposed to control media versus media with added 4 vs 8 mM 3-methyladenine, a known inhibitor of autophagy for 30 h. Activity of GAPDH was significantly decreased in a dose-dependent manner by 3-MA (Supplementary Figure 2B) . After the confirmation that GAPDH activity could serve as an accurate measure of autophagic activation in the embryos, blastocysts were collected from both in vivo and in vitro diabetic conditions and GAPDH activity was measured in each group (Fig. 3A  and B) . Our results indicate that these diabetic conditions result in an increase in the GAPDH activity, and we believe that this increase signifies an upregulation of autophagy in an attempt to protect the cell from damage as our other results suggest.
Autophagosomes are more abundant in oocytes of diabetic mice Previously, our laboratory has published results indicating that in vivo maternal diabetes leads to an increase of apoptosis in the ovarian follicles of mice (Chang et al. 2005) . Recently, our laboratory has also concluded that the mitochondria of diabetic oocytes display an abnormal morphology and distribution leading to a decrease in the metabolites. Furthermore, these oocytes display meiotic spindles defects and chromatin misalignment ). Using GFP-LC3 mice, Mizushima et al. observed a basal level of autophagy occurring at the unfertilized oocyte stage; however, much lower than that of the fertilized oocyte (Tsukamoto et al. 2008a) . Therefore, we hypothesize that the metabolic milieu of diabetes may lead to a dysregulation of autophagy in the oocytes of these mice.
By using transmission electron microscopy, we were able to obtain a more accurate estimation of the prevalence of autophagy during this stage (Fig. 4) . Our results indicate the presence of basal level autophagosomes in control oocytes. The numbers of autophagosomes per area increase in oocytes obtained from diabetic mice. This increase suggests an increased activation of the autophagic pathway.
Discussion
Although it has been determined that genetic removal of key players in the autophagic pathway leads to developmental arrest and embryonic malformations (Zheng et al. 2006 , Fimia et al. 2007 , Cecconi et al. 2008 , the dysregulation of this pathway in response to embryonic environmental stressors has yet to be elucidated. This study suggests that an autophagic response to the environmental stress of a hyperglycemic milieu occurs during the oocyte and blastocyst stages of development and that this event is heterogeneously triggered at the blastocyst stage with some cells undergoing cell death and others surviving, but significantly and perhaps permanently altered by the autophagic process. We speculate that these remaining cells may alter their fate, thereby changing the originally assigned cell lineages and possibly having developmental consequences. By exposing the embryos to an autophagic activator, rapamycin, we were able to observe an increase in autophagic proteins, AMBRA1 and LC3, as indicators of an increased activation of autophagy. Interestingly, the embryos display a heterogeneous autophagic response to culture conditions. This differential display of activation of a molecular pathway in embryos has been detailed before; however, this was in regard to apoptosis (Pampfer 2000) . In those studies, it was suggested that the ICM, which will develop into the embryo, and the TE, which develops into the extraembryonic tissues including the placenta, consists of separate 'microenvironments.' This internal separation establishes differential gene expression, different levels of ion and glucose transport, and a varying response to cytotoxic agents (Pampfer 2000) . Furthermore, cells within each of these compartments display a disparity. It has been reported, using cell lines derived from either the ICM or the TE, that the TE is more viable in a hyperglycemic environment, whereas the ICM is more susceptible to hyperglycemic environments, leading to an increased incidence in apoptosis (Pampfer 2000) . This is recapitulated in vivo as the number of cells in the ICM of embryos exposed to maternal hyperglycemia is reduced compared with controls (Lea et al. 1996 , Pampfer et al. 1997 .
In this study, we show a different pattern of expression than apoptosis. Although, the expression of AMBRA1 appears exclusively in the TE, the autophagic activation by LC3 is seen in random individual cells of the blastocyst. Murine embryos inherit a pool of maternal transcripts that are progressively degraded and replaced by the products of embryonic transcription. This embryonic genomic activation is triggered when the blastomeres still exhibit developmental plasticity and can change their cell fate (Zernicka-Goetz et al. 2009 ). It is possible that this differential autophagic response in single cells in the embryo during pre-implantation development affects the subsequent lineage allocation in that cell and its resulting daughter cells. We postulate that this early change in lineage patterning may result not only in the growth abnormalities of infants and placentas but also in the malformations commonly seen in fetuses from diabetic mothers.
While the effect of a maternal hyperglycemic environment on embryo development has been studied, much is still left unanswered. Our laboratory has previously published data establishing a result of increased apoptosis in murine blastocysts exposed to a hyperglycemic diabetic environment in vivo or in vitro (Moley et al. 1998a) . Furthermore, when transferred into pseudo-pregnant females, these exposed blastocysts display an increased rate of resorptions and malformations (Wyman et al. 2008) . Surprisingly, one-cell zygotes when transferred from diabetic to non-diabetic mice also demonstrated a significantly higher rate of malformations and growth retardation, suggesting an even earlier period of vulnerability of the zygote to hyperglycemia. More recent studies by our laboratory have confirmed this hypothesis. Recently, we determined that GV and MII oocytes from diabetic mice have biochemical and meiotic abnormalities that could predispose them to developmental problems postfertilization and perhaps implantation (Ratchford et al. 2007 ). We established that oocytes from diabetic mice have significantly lower ATP levels at both the GV and the MII stages (Ratchford et al. 2007 ).
In addition, we demonstrate a significantly higher number of autophagosomes in GV stage oocytes by electron microscopy ). Other groups have shown that the autophagic protein LC3 is not detected until after fertilization (Tsukamoto et al. 2008a ); however, we show a significant difference in activation in the unfertilized oocyte from diabetic mice. This raises the possibility that maternal proteins at this very early stage may be prematurely degraded by autophagy, resulting in oocytes deficient in protein and perhaps predisposed to increased autophagy and other abnormalities, as we see in the blastocysts from diabetic mice. Future studies will be designed to test this hypothesis. Recent studies have implicated GAPDH as a possible mediator and biochemical indicator of autophagic activation. Although the mechanism is not entirely elucidated, those studies demonstrated that overexpressing GAPDH in cells induced to undergo autophagy prevented this process. The conclusions were that GAPDH activity not only triggered metabolism of trioses within the glycolytic pathway but also, directly or indirectly, induced an increase in the transcription of ATG12, a key autophagic protein. Our study demonstrated a significant increase in the GAPDH activity within the whole blastocyst in response to maternal diabetes or in vitro high glucose. In addition, we confirmed that changes in this enzyme activity are predictive of either activation of autophagy by rapamycin or inhibition of autophagy by 3-methyladenine.
In conclusion, we show in this paper that the levels of autophagy are altered during oocyte and preimplantation development in response to environmental stressors (Fig. 5) . With the addition of the autophagy activator rapamycin, the levels of autophagy are increased in a cell-specific manner. In addition, the embryos cultured in a hyperglycemic environment mimicking maternal diabetes result in the elevation of the autophagic pathway. This elevation is also seen as an increase in the GAPDH activity, which has recently been suggested as an activator of the autophagic pathway. Furthermore, it appears that the autophagic pathway may be altered as early as the oocytes as a result of maternal diabetes. This early alteration in autophagy may result in changes in quality of the embryo after fertilization. However, further studies need to be conducted to validate this hypothesis. Overall, our data suggest that the hyperglycemic environment leads to an increased activation of autophagy during the oocyte growth phase and pre-implantation development, resulting in a differential response by the individual cells within the embryo.
Materials and Methods
Oocyte and embryo retrieval
To collect ovulated oocytes, control and diabetic B6SJL mice (Jackson Laboratory, Bar Harbor, ME, USA) received an injection of 10 IU hCG 2 days after PMSG priming (PSMG 2000 IU, National Hormone & Peptide Program, Torrance, CA, USA; hCG, Sigma). Oocytes were recovered from oviductal ampullae 13.5 h post-hCG, and cumulus cells were removed by incubating briefly in 1 mg/ml hyaluronidase. For embryo retrieval, the mice received the hormonal stimulation mentioned earlier and were then mated overnight with males of proven fertility. Mating was confirmed by the presence of a vaginal plug. Embryos for the in vivo blastocyst study (Fig. 3A) were obtained by flushing the uterine horns 96 h post-hCG. For the in vitro hyperglycemia and autophagy activation studies , the embryos were recovered from control mice 76 h post-hCG and mating and were cultured for 30 h in KSOM/0.25% BSA (v/v) (KSOM, Millipore Specialty Media, Danvers, MA, USA) and the indicated culture conditions at 37 8C in 5% CO 2 . 
Immunofluorescence staining
Embryos were collected and fixed in 3% paraformaldehyde in PBS/2% BSA (v/v) for 20 min at room temperature. The embryos were permeabilized in 0.5% Triton X-100 in PBS/2% BSA for 30 min. To block, the embryos were placed in 5% normal goat serum in PBS/2% BSA for 1 h. Then, the embryos were incubated in the primary antibody (1:250) in PBS/2% BSA overnight at 4 8C (LC3: Novus Biologicals, Littleton, CO, USA; AMBRA1: Cell Signaling Technology, Danvers, MA, USA). The embryos were washed three times in PBS/2% BSA and then incubated in secondary antibody (Alexa Fluor goat-anti-rabbit IgG 488; Molecular Probes, Eugene, OR, USA) for 45 min at room temperature. The embryos were rinsed three times again and placed in To-pro-3-iodide (Molecular Probes; 1:500) in PBS for 15 min. After three more rinses in PBS, the embryos were mounted on slides using Vectashield (Vecta, Burlingame, CA, USA) and visualized by confocal microscopy. All experimental groups (Figs 1A-C or D, E and 2) were conducted on the same day in order to use the same prepared secondary antibody preparation. Relative fluorescence was quantified by a blinded observer as described previously (Jungheim et al. 2010) .
Cell death assay
Apoptosis was detected using the In Situ Cell Death Detection kit, TMR red (Roche). The embryos were fixed and permeabilized as indicated in the immunofluorescence staining method. A positive control was obtained by treating embryos with DNase (0.5 ml/ml in PBS) for 20 min at 37 8C. Then, the embryos were incubated in the reaction mix, as per the manufacturer's specifications for 1 h at 37 8C in the dark. All subsequent reactions were also carried out in the dark. After three rinses in PBS/2% BSA, the embryos were counterstained with To-pro-3-iodide as mentioned earlier, rinsed, and then mounted on slides. The slides were viewed on a confocal microscope.
GAPDH activity assay
This assay has been previously described for individual cell activity measurements (Passonneau & Lowry 1993) . Individual mouse blastocysts were extracted in 20 mM phosphate buffer (pH 7.4), 0.02% BSA, 0.5 mM EDTA (pH 7.0), 5 mM B-Me, 0.25% glycerol, and 0.5% Triton X-100 (v/v) at room temperature for 120 min under oil and stored at K75 8C. A 0.1 ml aliquot was added to 1 ml GAPDH reagent containing 50 mM imidazole HCl (pH 7.0), 0.05% BSA, 1 mM EDTA (pH 7.0), 1 mM B-Me, 1 mM Na 2 HA S O 4 , 100 mM NAD, and 100 mM glyceraldehyde 3-phosphate at room temperature for 1 h. NADH standards in GAPDH reagent were added in this step. The reaction was stopped by the addition of 1 ml of 0.12 M NaOH and heated to 80 8C for 25 min. To amplify, a 0.5 ml aliquot was taken out and added to 10 ml NAD cycling reagent at room temperature overnight under oil for 15 000-fold amplification, as performed previously by our group (Chi et al. 2002) . The reaction was stopped by the addition of 1 ml 1 M NaOH and heated at 80 8C for 25 min. To read the samples, a 10 ml aliquot was taken out and added to 1 ml malate indicator reagent, as performed previously to obtain the NADH final reading in an A-1 Filter Fluorometer (Farrand Optical Components and Instruments, Valhalla, NY, USA; Chi et al. 2002) . All calculations were based on the internal NADH standards.
Generation of diabetic mice
To generate an in vivo diabetic model, 3-week-old female B6SJLF1 mice received a single injection of streptozotocin at a dose of 190 mg/kg. A tail-blood sample was measured for glucose concentrations via a Contour TS One Touch Glucometer (Bayer) 4 days after injection. Glucose levels O300 mg/dl were considered diabetic. Age-matched controls injected with PBS were used. Figure 5 Cartoon of the level of autophagy thought to exist in control versus diabetic oocytes and embryos. Although no autophagy was detected in MII oocytes from control mice (Tsukamoto et al. 2008a (Tsukamoto et al. , 2008b , we determined increased autophagosomes (in this study) and decreased ATP in MII oocytes from diabetic mice (Ratchford et al. 2007 ). In addition, although some autophagic proteins have been detected in control blastocysts, diabetic blastocysts demonstrated increased LC3 and AMBRA1 protein (this study) as well as decreased ATP (Chi et al. 2002) . The sinusoidal pattern of autophagy is an estimation based on prior work as well as this study. Furthermore, we speculate that increased autophagy at the oocyte stage may prematurely degrade maternal proteins leading to developmental arrest, and increased autophagy at the blastocyst stage may lead to abnormal degradation of embryonic proteins essential for proper development. 
Transmission electron microscopy
For ultrastructural analysis of autophagy, 100 oocytes of each group were processed for transmission electron microscopy as described previously in the Molecular Microbiology Imaging Facility at Washington University in St Louis (Gualtieri et al. 2009 ). The presence of autophagosomes was determined from electron micrographs at 10 000! magnification. To quantify the autophagosomes, the number of autophagosomes and the area in ten random sections of each group were recorded using ImageJ (National Institutes of Health, Bethesda, MD, USA). The following criteria for identifying autophagosomes were used: vesicles with a double membrane, between 0.3 and 2 mm, with clearly recognizable cytoplasmic contents and are not multilamellar bodies.
Statistical analysis
All experiments were completed in triplicate with at least ten embryos or oocytes per group in each experiment. The images in the figures are representative of the group of embryos in each group. For the GAPDH assay, a Student's t-test was performed.
Significance was defined as P!0.05.
